| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | UNION PAC CORP | 32,312 | 3,503,000 | 0.43% | ||
| 52 | TOKAI PHARMACEUTICALS INC COM | 230,000 | 3,482,000 | 0.43% | ||
| 53 | INTERCEPT PHARMACEUTICALS INCORPORATED | 14,565 | 3,447,000 | 0.43% | ||
| 54 | ProQR Therapeutics NV | 200,000 | 3,438,000 | 0.42% | ||
| 55 | AERIE PHARMACEUTICALS INC COM | 163,516 | 3,383,000 | 0.42% | ||
| 56 | CYMABAY THERAPEUTICS INC | 490,355 | 3,354,000 | 0.41% | ||
| 57 | CVS HEALTH CORP | 39,810 | 3,168,000 | 0.39% | ||
| 58 | V F CORP | 47,900 | 3,163,000 | 0.39% | ||
| 59 | RADIUS HEALTH INCORPORATED COM NEW | 150,000 | 3,150,000 | 0.39% | ||
| 60 | SALIX PHARMACEUTICALS INC | 20,000 | 3,125,000 | 0.39% | ||
| 61 | SELECT SECTOR SPDR TR | 48,853 | 3,122,000 | 0.39% | ||
| 62 | ARRAY BIOPHARMA INC | 873,922 | 3,120,000 | 0.39% | ||
| 63 | ACCELERON PHARMA INC | 100,000 | 3,024,000 | 0.37% | ||
| 64 | INCYTE CORP | 61,173 | 3,001,000 | 0.37% | ||
| 65 | AVANIR PHARMACEUTICALS INC CL | 250,000 | 2,980,000 | 0.37% | ||
| 66 | TJX COS INC NEW | 50,000 | 2,959,000 | 0.37% | Call | |
| 67 | SCHLUMBERGER LTD | 28,790 | 2,928,000 | 0.36% | ||
| 68 | YUM BRANDS INC | 39,910 | 2,873,000 | 0.35% | ||
| 69 | PTC THERAPEUTICS INC | 63,625 | 2,800,000 | 0.35% | ||
| 70 | TOWERS WATSON & CO | 28,000 | 2,786,000 | 0.34% | ||
| 71 | SAGE THERAPEUTICS INC | 87,924 | 2,770,000 | 0.34% | ||
| 72 | Otonomy Inc | 111,085 | 2,666,000 | 0.33% | ||
| 73 | Nice Systems LTD Sponsored | 64,542 | 2,622,000 | 0.32% | ||
| 74 | GOOGLE INC | 4,540 | 2,621,000 | 0.32% | ||
| 75 | COLGATE PALMOLIVE CO | 40,099 | 2,615,000 | 0.32% | ||
| 76 | IRONWOOD PHARMACEUTICALS INC | 194,200 | 2,516,000 | 0.31% | ||
| 77 | CATALYST PHARMACEUTICALS INC | 685,500 | 2,276,000 | 0.28% | ||
| 78 | VANDA PHARMACEUTICALS INC COM | 218,390 | 2,267,000 | 0.28% | ||
| 79 | MACROGENICS INC | 107,781 | 2,253,000 | 0.28% | ||
| 80 | ISHARES NASDAQ BIOTECHNOLOGY ETF | 3,784 | 2,227,000 | 0.28% | ||
| 81 | LA JOLLA PHARMACEUTICAL CO | 223,330 | 2,146,000 | 0.27% | ||
| 82 | TREVENA INC | 331,111 | 2,126,000 | 0.26% | ||
| 83 | ARENA PHARMACEUTICALS INC | 500,000 | 2,095,000 | 0.26% | ||
| 84 | RELYPSA INC | 97,100 | 2,048,000 | 0.25% | ||
| 85 | AKEBIA THERAPEUTICS INC | 89,817 | 1,988,000 | 0.25% | ||
| 86 | IMMUNOMEDICS INCORPORATED | 534,050 | 1,987,000 | 0.25% | ||
| 87 | ACTINIUM PHARMACEUTICALS INC | 291,300 | 1,952,000 | 0.24% | ||
| 88 | SNAP ON INC | 16,100 | 1,949,000 | 0.24% | ||
| 89 | CELLADON CORP | 185,656 | 1,942,000 | 0.24% | ||
| 90 | KITE PHARMA INCORPORATED | 67,970 | 1,937,000 | 0.24% | ||
| 91 | MASTERCARD INCORPORATED | 26,000 | 1,922,000 | 0.24% | ||
| 92 | BLUEBIRD BIO INC COM | 53,405 | 1,916,000 | 0.24% | ||
| 93 | ZAFGEN INC COM | 97,100 | 1,908,000 | 0.24% | ||
| 94 | Alder Biopharmaceutl | 150,000 | 1,902,000 | 0.23% | ||
| 95 | Marinus Pharmaceuticals Inc | 293,533 | 1,899,000 | 0.23% | ||
| 96 | ELLOMAY CAPITAL LIMITED | 191,202 | 1,891,000 | 0.23% | ||
| 97 | PROSENSA HLDG N V SHS USD | 219,345 | 1,849,000 | 0.23% | ||
| 98 | ONCOMED PHARMACEUTICALS INC COM | 97,100 | 1,838,000 | 0.23% | ||
| 99 | MANNKIND CORP | 300,000 | 1,773,000 | 0.22% | Put | |
| 100 | TJX COS INC NEW | 27,600 | 1,633,000 | 0.20% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001178913-14-003634, filed 2014.11.20).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
